Immunosuppression as a Risk Factor for De Novo Angiotensin II Type Receptor Antibodies Development after Kidney Transplantation.

J Clin Med · 2021 · PMC8625545 · PMID 34830672

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

at the limit of significanceno p-value reported

9.1%, p = 0.05), but at the limit of significance.

also in 326 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.